NCT02257151View on ClinicalTrials.gov

Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy Adult
Interventions
DRUG

BMS-986142

DRUG

Placebo

Trial Locations (1)

90630

Wcct Global, Llc, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02257151 - Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects | Biotech Hunter | Biotech Hunter